Middle East Experience

Leifer fled from Australia to Israel in 2008 after allegations of sexual abuse surfaced against her, and has evaded extradition since 2014 by claiming to be mentally unfit for trial.
Source: Jerusalem Post
Full Article: High Court rules Malka Leifer fit for extradition

Part of the claims of Iran’s defense officials is that its radar can also track hundreds of threats.
Source: Jerusalem Post
Full Article: Iran claims advances in radar that it says can reach Israel

Romania is a member of the European Union, which is at odds with the US and Israel over how best to handle Iran’s military and nuclear threat.
Source: Jerusalem Post
Full Article: Arms embargo against Iran must be reinstated, Ashkenazi tells Romanian FM

Egypt, which welcomed the recent normalization agreement between Israel and the United Arab Emirates, and has its own longstanding peace treaty with Israel, does not seem to be as enthusiastic about Sudan doing the same.
Source: Al Monitor
Full Article: Would Egypt support Sudan-Israel normalization deal?

The Iranian leader tweeted about "Jews" in English and Arabic but not in other languages.
Source: Jerusalem Post
Full Article: Iran's Ali Khamenei slammed for antisemitic tweets against Jared Kushner

Police revealed the entire story of how the brutal act came about.
Source: Jerusalem Post
Full Article: Eilat gang-rape: 11 suspects indicted, four for rape, seven for assisting

A song by Lebanese pop singer Nawal Al-Zoghbi was blasted from a mosque in Nabatieh after a mishap with the loudspeakers..
Source: Your Middle East
Full Article: Mosque in Lebanon accidentally blasts pop song

Some are calling for a boycott of the upcoming Jordanian parliamentary elections in protest against anticipated manipulation.
Source: Al Monitor
Full Article: Why Jordan’s Islamists are boycotting elections

Saudia Airlines has set coronavirus guidelines and requirements for travelers arriving in Saudi Arabia amid the COVID-19 outbreak, despite the continued suspension of international flights.Read the latest updates in our dedicated coronavirus section.Once air travel resumes, all arrivals will be required to self-isolate for seven days in their homes. Health practitioners, however, are partially exempt and will only need to quarantine for three days if they have a negative PCR test result at the end of the isolation period.Travelers will be required to fill out and sign a health declaration form and submit it to the health control center upon arrival at the airport.They must also download and register the Tatamman and Tawakkalna mobile applications used for COVID-19 monitoring in the Kingdom. Saudia said guests are required register a home location on the Tatamman application within eight hours of arrival and must submit a daily health assessment as well.Travelers are also urged to monitor any possible COVID-19 symptoms, including dry cough and fever, and to visit a healthcare center or call 937 if symptoms do appear.For all the latest headlines, follow our Google News channel online or via the app.Authorities have not yet set a date for the resumption of international travel to and from the Kingdom. However, Saudi Arabia reopened its land borders in August to citizens and their non-Saudi family members who wish to return to the country.Read more:UAE reports 614 new COVID-19 cases amid surge in infections300 hotel guests quarantined in Jordan after chef gets COVID-19Dubai announces ‘retirement visa’ scheme for resident expatriates, foreigners
Source: Al Arabiya
Full Article: Coronavirus: Saudia Airlines sets COVID-19 guidelines for travel to Saudi Arabia

Last week, US-based biotechnology company Tyme Technologies announced a new oral treatment for the coronavirus that could prove pivotal in the fight against COVID-19.The drug, named TYME-19,could be given to patients that test positive for COVID-19 before they are hospitalized, and could also be taken by front line health care workers and high-risk individuals to minimize the chance of infection, said a representative from Tyme Technologies.TYME-19 is made from synthesized antiviral bile acid and has proved efficient at fighting COVID-19 in preclinical trials, the firm said at the time. Tyme Technologies partnered with doctors from the Massachusetts General Hospital and the Weill Cornell Medical Center for clinical trials of the drug.Read the latest updates in our dedicated coronavirus section.“TYME-19 is the only agent in this class of metabolic-based medicines derived from bile acids. It has a unique mechanism of action modeled after the body’s own defenses against virus infection. TYME-19 is oral and instant, differing from all injectables including vaccines,” Steven Hoffman, co-founder, chief executive, and chief science officer of Tyme Technologies told Al Arabiya English on Wednesday.Here’s everything you need to know about the new treatment:Does TYME-19 stop the coronavirus?So far, clinical trials have proven successful, with TYME-19 stopping COVID-19 from replicating in treated cells without causing damage.“In preclinical testing, TYME-19 repeatedly prevented COVID-19 viral replication without cytotoxicity in treated cells. Previous preclinical research has also shown select bile acids like TYME-19 have had broad antiviral activity,” Hoffman added.However, Hoffman added that further testing is necessary, and highlighted the importance of the firm’s partnership with Massachusetts General Hospital and Weill Cornell for further testing opportunities. A new proof-of-concept study is set to take place to evaluate the effectiveness of TYME-19 versus a placebo in newly diagnosed patients with high-risk factors. The study is set to take place before the end of 2020.“Positive results from the proof-of-concept study could lead to a development program in which TYME-19 is studied as a potential new oral treatment for patients with COVID-19 before they require hospitalization, and/or as prophylaxis for high-risk individuals and front-line workers,” Hoffman explained.How was TYME-19 developed?Tyme Technologies developed TYME-19 based on experience the firm had in developing a different type of bile acid, TYME-18, for its anticancer products.“TYME-19 is part of a family of metabolic agents called bile acids that have previously been associated strictly with liver disease but recently are recognized for their potential utility to treat multiple diseases. Bile acids are important regulators for many cellular functions throughout the central nervous, cardiovascular and metabolic systems,” Hoffman said.Viruses attack the ability of the body’s cells to make proteins and lipids, instead using this process to replicate itself. TYME-19 has been shown to prevent viruses from doing so, Hoffman went on to explain.“In preclinical testing, TYME-19 has been shown to counteract these effects, preventing viral replication, by reducing ER stress. In addition, TYME-19 is believed to physically degrade viruses by solubilizing the protective lipid layer and other structural components, which prevent a virus from binding to and infecting a cell,” he said.For all the latest headlines, follow our Google News channel online or via the app.How is TYME-19 different from other COVID-19 medications in development?Hoffman highlighted the company’s belief in TYME-19's safety as a COVID-19 drug, noting that it can be taken orally and is stable at room temperature – thus lowering the risk of the drug degrading through improper care.TYME-19 will also be “relatively inexpensive to manufacture,” Hoffman said – an important factor to consider given the global need coronavirus treatment. The drug can also help protect front line health workers and high-risk populations, crucial to slowing the spread of the virus before a cure and vaccine can be developed, he said.“Doctors need more tools between hospital care and vaccines. Until there is a cure (not just a vaccine), doctors will need multiple medicines for their treatment regimen … Vaccines are a key part of the solution for a pandemic, but there needs to be better therapies available while the vaccines are being developed,” Hoffman added.Read more:Coronavirus: New oral treatment for COVID-19 revealed, trials to begin soonScientists test cat coronavirus drugs for treating COVID-19 in humansCoronavirus: COVID-19 antibody drugs tested for patient treatment
Source: Al Arabiya
Full Article: Coronavirus: Everything you need to know about TYME-19, a new COVID-19 treatment